Clin2
NCT07555743Possibly a fitNot yet recruiting

New Insomnia Treatment for Depression Patients

InsomniaMajor Depressive Disorder

Treatments studied

Part of Brain & nervous system, Mental health clinical trials.

This study tests whether a new sleep medication called daridorexant helps people with depression who also struggle with insomnia. You would take this medication for several weeks while researchers track how it affects your sleep and mood.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
134 people
Ages
18 years to 99 years
Study type
Interventional

Who can take part

  • Age 18 or older
  • Current diagnosis of major depression (moderate to severe) that has been stable on the same antidepressant dose for at least 4 weeks
  • Insomnia disorder confirmed by a healthcare provider, with moderate-to-severe sleep problems
  • Willing to stop or taper certain sleep medications (like benzodiazepines or melatonin) before starting the study
  • No other active psychiatric conditions like bipolar disorder, schizophrenia, or active psychosis
  • Able to attend all study visits and complete questionnaires about your mood and sleep

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07701928Not yet recruiting· Phase 2
Daridorexant for sleep and alcohol use disorder

This trial tests if the sleep medication daridorexant can help people who have both insomnia and alcohol use disorder. It looks at whether the drug improves sleep and reduces drinking.

Spokane, Washington
NCT07328594Not yet recruiting· Phase 4
Sleep medication to help smokers quit or cut back

This study tests whether a new sleep medication, daridorexant, can help smokers sleep better and feel more alert during the day, while also supporting their efforts to quit or reduce smoking. You will monitor your sleep at home, keep a diary, and take short mobile tests for 3 weeks.

Portland, Oregon
NCT07392177Recruiting· Phase 2
Understanding the brain's role in insomnia

This trial tests whether a part of the brain called the locus coeruleus is involved in insomnia. It involves sleep questionnaires and possibly brain imaging to understand your sleep problems better.

Macquarie Park, New South Wales
NCT07136415Recruiting· Phase 4
Comparing digital therapy, trazodone, and daridorexant for menopause insomnia

This trial tests three different treatments for insomnia that started or got worse during the menopausal transition. One is a digital therapy app, and the others are two different medications. The goal is to see which works best for women aged 40–62 who are in the early stages of menopause.

Boston, Massachusetts
NCT07743931Not yet recruiting
Combined CPAP and medication for sleep apnea with insomnia

This study is testing a new approach for people who have both sleep apnea and insomnia, called 'COMISA'. It looks at whether using a CPAP machine together with a medication (daridorexant) helps improve their sleep better than standard care.

Marseille
NCT07542756Recruiting· Phase 4
Testing Common Sleep Medications for Insomnia

This study compares how well different over-the-counter and prescription sleep medications work for insomnia. Researchers will guide you through trying medications one at a time to find what works best for your sleep problems.

Philadelphia, Pennsylvania

Hear when a new Insomnia trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.